Join the thousands of professionals, journalists, government leaders, law firms, associations, and others who turn to EIN News for complete news coverage.
Introgen cuts 29% of jobs as it moves to market cancer therapy6 Jul 2008 18:30 GMT ... The jobs eliminated are mainly associated with Advexin development and regulatory submission programs that have ... it applied with the U.S. Food and Drug Administration to market its newest cancer drug. ... for priority review of its Advexin p53 treatment. If the drug is approved for priority ...
Do you want to reach readers of Arizona politics? Zimbabwe agriculture? A to Z we have you covered.
For less than a dollar a day, place your ad on the exact pages that will do you the most good.
Try our 7 day free trial.